Any administration of immunoglobulins during the vaccination course or within one month prior to the first vaccination. Any continuous suppressive antiviral oral therapy within the 6 months prior to entry.
Please refer to this study by its ClinicalTrials. Female subjects who are pregnant, would preclude entry into the study?
known hypersensitivity to vaccination or to any component of the vaccine. Recent clinical history or evidence of renal dysfunction Life-threatening loiking serious cardiac NYHA grades III-IVlactating or planning a pregnancy before one month after the last vaccine dose Patient is immuno-compromised or is receiving immuno-modifying therapy of any kind, 5'8 black with blond hair and green eyes, READING A REALLY GOOD BOOK, no diseases.
Any vaccine administration less than one week before or after a study vaccination. Any vaccination against herpes simplex.
HIV positive at the time of enrollment Clinical s of acute or febrile illness at the time of entry into the study. Topical corticoid therapy is allowed. History of erythema multiforme.
Any eros escorts baltimore of MPL. Simultaneous participation in any other fot trial of an investigational drug or vaccine concurrent with this study or during the period beginning 30 days prior to entry into the study or 5 half-lives of the drug Recent history of alcoholism or drug abuse Recent clinical history or evidence of ificant hepatic disease History of a current acute or chronic auto immune disease.
History of herpetic keratitis.